Highlights from NextGen Biomed 2026
March 27, 2026
CPC Scientific was pleased to return to NextGen Biomed 2026 as a Silver Sponsor! From March 24–25, we joined global innovators and partners at the QEII Centre in London, UK to discuss the latest developments shaping peptide and oligonucleotide manufacturing.
Presentation on Peptide Manufacturing Innovations
On March 24, Joseph Denby (Sr. Manager of Business Development) kicked the morning off with his presentation, “Innovative Peptide Manufacturing Methods That Scale.”
Joseph’s presentation featured a case study on how CPC Scientific’s SPPS process innovations have enabled multi-kilogram delivery of a pharmaceutically-relevant polypeptide within a challenging timeline. The talk highlighted how advanced process design can accelerate sustainability, cost efficiency, and delivery timelines for large-scale TIDES synthesis.
Interested in learning more? Stay tuned for the presentation video, or dive into the details with our white papers below:
Advancing the Future of Greener TIDES Manufacturing
Our team members (Sheri Ambriz, MBA, Clàudia Badia i Lopez, and Joseph Denby) had a great time connecting with NextGen Biomed attendees and discussing the evolving needs of sustainable peptide and oligo drug development at scale.
Throughout the conference, one key message was reinforced: as TIDES innovation accelerates, scalable manufacturing strategies must keep pace. From growing demand for GLP-1 receptor agonists, to rising expectations around sustainable synthesis and advanced analytics, the path forward depends on CDMOs that can deliver the highest quality standards alongside industrial-scale execution.
At CPC Scientific, we help partners address that challenge with large-scale GMP peptide and oligonucleotide manufacturing built for performance, sustainability, and regulatory confidence. Through our advanced process design and end-to-end CDMO expertise, we support the development of life-changing therapeutics with reduced environmental footprint and increased manufacturing efficiency.
Thank you to everyone who connected with us in London this week! We look forward to continuing the conversations and collaborations that have begun at NextGen Biomed 2026.
Ready to explore a CDMO partnership that delivers quality, speed, and sustainability?
Connect with our team to learn how strategic process design can enhance environmental impact and delivery timelines for your peptide and oligonucleotide programs at scale.
Latest News & Resources
We recently caught up with Chief Solutions Officer Baosheng Liu, PhD to discuss how CPC Scientific is shaping the future of peptide and oligo manufacturing, and how the CDMO industry is evolving in the next decade...
Sheri Ambriz, MBA took the stage at TIDES USA 2025 in San Diego, CA, to share insights on green approaches to peptide and peptide–oligonucleotide conjugate manufacturing.
Gain insights from Joseph Denby's rapid-fire Q&A spotlight at NextGen Biomed 2025, where he explores the landscape of peptide and oligo APIs, as well as the role of green chemistry in manufacturing.
At NextGen Biomed 2025, Joseph Denby delivered a cutting-edge presentation highlighting the critical role green chemistry plays in the sustainable production of peptide APIs and peptide–oligo conjugates...
We are excited to share that CPC Scientific Inc. has officially received the Good Manufacturing Practice (GMP) Certificate in accordance with the ISO 22716:2007(E) Cosmetic Guidelines.
In this case study, we demonstrate the synthesis of a Goserelin peptide API impurity through a convergent peptide fragment strategy, expanding our approach to include the unprotected side chains of histidine, tryptophan, and arginine...
We recently caught up with Chief Solutions Officer Baosheng Liu, PhD to discuss how CPC Scientific is shaping the future of peptide and oligo manufacturing, and how the CDMO industry is evolving in the next decade...
Sheri Ambriz, MBA took the stage at TIDES USA 2025 in San Diego, CA, to share insights on green approaches to peptide and peptide–oligonucleotide conjugate manufacturing.
Gain insights from Joseph Denby's rapid-fire Q&A spotlight at NextGen Biomed 2025, where he explores the landscape of peptide and oligo APIs, as well as the role of green chemistry in manufacturing.
At NextGen Biomed 2025, Joseph Denby delivered a cutting-edge presentation highlighting the critical role green chemistry plays in the sustainable production of peptide APIs and peptide–oligo conjugates...
We are excited to share that CPC Scientific Inc. has officially received the Good Manufacturing Practice (GMP) Certificate in accordance with the ISO 22716:2007(E) Cosmetic Guidelines.
In this case study, we demonstrate the synthesis of a Goserelin peptide API impurity through a convergent peptide fragment strategy, expanding our approach to include the unprotected side chains of histidine, tryptophan, and arginine...